Furthermore, the authors verified this result with clinical data showing that low expression of miR‐139‐5p and high expression of SLC7A11 are associated with a poor prognosis, indicating that miR‐139‐5p may represent a new biomarker of pancreatic cancer.27 The gene discussed is SLC7A11; the disease is pancreatic neoplasm.